Detalhe da pesquisa
1.
Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma.
Blood
; 114(13): 2721-9, 2009 Sep 24.
Artigo
Inglês
| MEDLINE | ID: mdl-19633198
2.
Valency of HER2 Targeting Antibodies Influences Tumor Cell Internalization and Penetration.
Mol Cancer Ther
; 20(10): 1956-1965, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34253591
3.
Calicheamicin Antibody-Drug Conjugates with Improved Properties.
Mol Cancer Ther
; 20(6): 1112-1120, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33722856
4.
Evaluation and use of an anti-cynomolgus monkey CD79b surrogate antibody-drug conjugate to enable clinical development of polatuzumab vedotin.
Br J Pharmacol
; 176(19): 3805-3818, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31270798
5.
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast Cancer.
Mol Cancer Ther
; 17(3): 638-649, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29282299
6.
Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers.
Mol Cancer Ther
; 16(5): 871-878, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28223423
7.
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast Cancer.
Mol Cancer Ther
; 18(11): 2182, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31676543
8.
Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging.
Clin Cancer Res
; 15(21): 6674-82, 2009 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19861458